This combination is not recommended for people with ASCVD or HF due to potential hemodynamic stress and lack of outcome data, especially when alternatives with proven benefits are available
Limited data with XIGDUO XR or dapagliflozin in pregnant women are not sufficient to determine drugassociated risk for major birth defects or miscarriage
Do not change the drip rate or move the IV bag as this may affect your treatment/therapy outcome
To normalize the data and remove the impact of changes in prescribing volumes for all drugs, we divided by the total number of prescriptions in Truveta Data each month
Unlike some diabetes medications that require multiple daily administrations, Semaglutide injections offer a simple and easy-to-follow dose regimen, which can enhance adherence and patient satisfaction
RM: Conceptualization, Data curation, Formal analysis, Investigation, Software, Validation, Writing original draft